ALEMBIC
Back to Balance Sheet
|
ALEMBIC Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹32 Cr | ₹34 Cr | ₹48 Cr | ₹40 Cr | ₹48 Cr |
What is the latest Contingent Liabilities ratio of ALEMBIC ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹32 Cr |
| Mar2024 | ₹34 Cr |
| Mar2023 | ₹48 Cr |
| Mar2022 | ₹40 Cr |
| Mar2021 | ₹48 Cr |
How is Contingent Liabilities of ALEMBIC Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹32 Cr | -6.78 | |
| Mar2024 | ₹34 Cr | -29.15 | |
| Mar2023 | ₹48 Cr | 19.69 | |
| Mar2022 | ₹40 Cr | -16.24 | |
| Mar2021 | ₹48 Cr | - | |
Compare Contingent Liabilities of peers of ALEMBIC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALEMBIC | ₹2,369.8 Cr | 1.4% | -6.9% | -19% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,341.0 Cr | -2.3% | -7.3% | -12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,401.0 Cr | 0.8% | -5.8% | 4.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,175.0 Cr | 0.8% | 3.7% | 20.8% | Stock Analytics | |
| CIPLA | ₹107,100.0 Cr | 0.7% | -11.2% | -6.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,715.9 Cr | -1.4% | -3.8% | -1.3% | Stock Analytics | |
ALEMBIC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALEMBIC | 1.4% |
-6.9% |
-19% |
| SENSEX | -1% |
-4.7% |
6% |
You may also like the below Video Courses